Teikoku Pharma USA and Eagle Pharmaceuticals Enter into License Agreement for Docetaxel, Non-Alcohol Formula

SAN JOSE, Calif., Oct. 15, 2015 -- (Healthcare Sales & Marketing Network) -- Teikoku Pharma USA Inc. ("TPU") today announced that it has entered into an exclusive license agreement with Eagle Pharmaceuticals, Inc. to market, sell, and distribute... Biopharmaceuticals, Oncology, LicensingTeikoku Pharma, Eagle Pharmaceuticals, Docetaxel
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news